If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
545.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (1.852%)
Market Cap: £89.24m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Full Year Trading Statement

26 Jan 2022 07:00

RNS Number : 6308Z
Anpario PLC
26 January 2022
 
Anpario plc("Anpario" or the "Group")

 

Full Year Trading Statement

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2021.

 

Trading update

The Group has delivered a strong operating performance despite a number of challenges in global markets and supply chains due to the pandemic. Earnings are expected to be in line with current market expectations with full year sales expected to be not less than £33m.

 

Sales growth has been achieved across all of our regions, Asia, Europe, Middle-East and Africa (MEA) and the Americas. Some territories are still experiencing weakness linked to the pandemic, particularly in parts of MEA and Asia. However, a number of key market developments have provided MEA with the strongest segment growth, helping it recover from the previous year. The impact in Asia of lock-downs and reduced tourism was more than offset by strong performances in China and Australasia.

 

We have continued to experience increased logistics and raw material price inflation, the cost of which is being passed on through sales price increases. We are seeing some encouraging signs that cost price inflation has begun to stabilise and the improving international travel situation will help our sales teams drive new business development initiatives.

 

The Board would like to thank all stakeholders, especially our staff around the world, who have adapted to new ways of working and put every effort into ensuring continued production and delivery of our products to customers and our subsidiaries around the world.

 

Financial position

Our financial position remains very strong with year-end cash balances of £15.5m (31 Dec 2020: £15.8m). Global logistics challenges led us to absorb cash into working capital, particularly through the first part of the year, to ensure local supply to our customers. Through H2 we have increased cash by £0.9m, after £2.1m of dividend payments and further capital investments of £0.9m, including the Solar Panel installation to reduce our carbon emissions.

 

Final results date

The Group expects to announce its final results for the year ended 31 December 2021 on 16 March 2022.

 

 

Enquiries:

 

Anpario plc

Richard Edwards, CEO

+44(0) 777 6417 129

Marc Wilson, Group Finance Director

+44(0) 1909 537380

 

Peel Hunt LLP (Nomad and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Lalit Bose

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGGGUPPPPA
Date   Source Headline
6th Aug 20074:13 pmRNSDirector/PDMR Shareholding
1st Aug 20077:02 amRNSChange of Adviser
30th Jul 200712:43 pmRNSDirectorate Change
30th Jul 20078:00 amRNSInterim Results
30th Jul 20078:00 amRNSInterim Results
19th Jul 20072:29 pmRNSBlocklisting Interim Review
16th Jul 20072:00 pmRNSAdditional Listing
12th Jul 200711:30 amRNSTrading Statement
18th Jun 20079:24 amRNSRPM Production Stopped
4th Jun 20074:50 pmRNSDirector/PDMR Shareholding
4th Jun 200711:14 amRNSDirectorate Change
25th May 200710:18 amRNSMine Training Centre
4th May 200712:02 pmRNSDividend Declaration
26th Apr 20077:02 amRNSFinal Results
16th Apr 20073:02 pmRNSDirector/PDMR Shareholding
13th Apr 20073:11 pmRNSDirector/PDMR Shareholding
13th Apr 20073:06 pmRNSRustenburg Directorate
3rd Apr 20072:42 pmRNSDirector/PDMR Shareholding
2nd Apr 200711:17 amRNSDirectorate Change
30th Mar 20073:40 pmRNSAGM Statement
28th Mar 20072:51 pmRNSDirector/PDMR Shareholding
19th Mar 20071:10 pmRNSDividend re-investment
19th Mar 20071:01 pmRNSDirector/PDMR Shareholding
13th Mar 20072:10 pmRNSDividend conversion rate
13th Mar 200711:00 amRNSDirector/PDMR Shareholding
2nd Mar 200712:22 pmRNSDirectorate Change
2nd Mar 20079:34 amRNSRustenburg Platinum
2nd Mar 20079:13 amRNSDirector/PDMR Shareholding
27th Feb 20072:01 pmRNSDirectorate Change
14th Feb 20072:00 pmRNSDirectorate Change
12th Feb 20077:01 amRNSFinal Results
12th Feb 20077:00 amRNSDividend Declaration
18th Jan 20072:40 pmRNSBlocklisting Interim Review
15th Jan 20079:23 amRNSAdditional Listing
12th Jan 20073:30 pmRNSBlocklisting Interim Review
14th Dec 20061:05 pmRNSBEE Transaction
12th Dec 200610:00 amRNSAmandelbult mine
11th Dec 20069:15 amRNSPreference Shares
11th Dec 20069:00 amRNSConversion of pref shares
6th Dec 200611:45 amRNSDirectorate Change
6th Dec 200611:06 amRNSFacility visit
29th Nov 200612:00 pmRNSTrading Statement
27th Nov 200611:56 amRNSResult of EGM
9th Nov 200610:48 amRNSSchedule 1 - Kiotech Int. Plc
9th Nov 20067:00 amRNSFacility visit
8th Nov 20061:02 pmRNSDirector/PDMR Shareholding
8th Nov 200612:00 pmRNSBEE Transaction
7th Nov 20067:01 amRNSDirectorate Change
3rd Nov 20062:00 pmRNSAnooraq-Platinum Proj Update
3rd Nov 20067:30 amRNSRestoration- Kiotech Intl plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.